231 related articles for article (PubMed ID: 19242543)
1. IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy.
Al-Zeer MA; Al-Younes HM; Braun PR; Zerrahn J; Meyer TF
PLoS One; 2009; 4(2):e4588. PubMed ID: 19242543
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10.
Coers J; Bernstein-Hanley I; Grotsky D; Parvanova I; Howard JC; Taylor GA; Dietrich WF; Starnbach MN
J Immunol; 2008 May; 180(9):6237-45. PubMed ID: 18424746
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia trachomatis Is Resistant to Inclusion Ubiquitination and Associated Host Defense in Gamma Interferon-Primed Human Epithelial Cells.
Haldar AK; Piro AS; Finethy R; Espenschied ST; Brown HE; Giebel AM; Frickel EM; Nelson DE; Coers J
mBio; 2016 Dec; 7(6):. PubMed ID: 27965446
[TBL] [Abstract][Full Text] [Related]
4. Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins.
Al-Zeer MA; Al-Younes HM; Lauster D; Abu Lubad M; Meyer TF
Autophagy; 2013 Jan; 9(1):50-62. PubMed ID: 23086406
[TBL] [Abstract][Full Text] [Related]
5. Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages.
Finethy R; Jorgensen I; Haldar AK; de Zoete MR; Strowig T; Flavell RA; Yamamoto M; Nagarajan UM; Miao EA; Coers J
Infect Immun; 2015 Dec; 83(12):4740-9. PubMed ID: 26416908
[TBL] [Abstract][Full Text] [Related]
6. Genetic Screen in Chlamydia muridarum Reveals Role for an Interferon-Induced Host Cell Death Program in Antimicrobial Inclusion Rupture.
Giebel AM; Hu S; Rajaram K; Finethy R; Toh E; Brothwell JA; Morrison SG; Suchland RJ; Stein BD; Coers J; Morrison RP; Nelson DE
mBio; 2019 Apr; 10(2):. PubMed ID: 30967464
[TBL] [Abstract][Full Text] [Related]
7. Loss of the interferon-γ-inducible regulatory immunity-related GTPase (IRG), Irgm1, causes activation of effector IRG proteins on lysosomes, damaging lysosomal function and predicting the dramatic susceptibility of Irgm1-deficient mice to infection.
Maric-Biresev J; Hunn JP; Krut O; Helms JB; Martens S; Howard JC
BMC Biol; 2016 Apr; 14():33. PubMed ID: 27098192
[TBL] [Abstract][Full Text] [Related]
8. The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens.
Liesenfeld O; Parvanova I; Zerrahn J; Han SJ; Heinrich F; Muñoz M; Kaiser F; Aebischer T; Buch T; Waisman A; Reichmann G; Utermöhlen O; von Stebut E; von Loewenich FD; Bogdan C; Specht S; Saeftel M; Hoerauf A; Mota MM; Könen-Waisman S; Kaufmann SH; Howard JC
PLoS One; 2011; 6(6):e20568. PubMed ID: 21698150
[TBL] [Abstract][Full Text] [Related]
9. The E2-like conjugation enzyme Atg3 promotes binding of IRG and Gbp proteins to Chlamydia- and Toxoplasma-containing vacuoles and host resistance.
Haldar AK; Piro AS; Pilla DM; Yamamoto M; Coers J
PLoS One; 2014; 9(1):e86684. PubMed ID: 24466199
[TBL] [Abstract][Full Text] [Related]
10. Regulation of chlamydial infection by host autophagy and vacuolar ATPase-bearing organelles.
Yasir M; Pachikara ND; Bao X; Pan Z; Fan H
Infect Immun; 2011 Oct; 79(10):4019-28. PubMed ID: 21807906
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.
Roshick C; Wood H; Caldwell HD; McClarty G
Infect Immun; 2006 Jan; 74(1):225-38. PubMed ID: 16368976
[TBL] [Abstract][Full Text] [Related]
12. Inactive and active states of the interferon-inducible resistance GTPase, Irga6, in vivo.
Papic N; Hunn JP; Pawlowski N; Zerrahn J; Howard JC
J Biol Chem; 2008 Nov; 283(46):32143-51. PubMed ID: 18784077
[TBL] [Abstract][Full Text] [Related]
13. IRG and GBP host resistance factors target aberrant, "non-self" vacuoles characterized by the missing of "self" IRGM proteins.
Haldar AK; Saka HA; Piro AS; Dunn JD; Henry SC; Taylor GA; Frickel EM; Valdivia RH; Coers J
PLoS Pathog; 2013; 9(6):e1003414. PubMed ID: 23785284
[TBL] [Abstract][Full Text] [Related]
14. The activation mechanism of Irga6, an interferon-inducible GTPase contributing to mouse resistance against Toxoplasma gondii.
Pawlowski N; Khaminets A; Hunn JP; Papic N; Schmidt A; Uthaiah RC; Lange R; Vopper G; Martens S; Wolf E; Howard JC
BMC Biol; 2011 Jan; 9():7. PubMed ID: 21276251
[TBL] [Abstract][Full Text] [Related]
15. The bacterial effector GarD shields Chlamydia trachomatis inclusions from RNF213-mediated ubiquitylation and destruction.
Walsh SC; Reitano JR; Dickinson MS; Kutsch M; Hernandez D; Barnes AB; Schott BH; Wang L; Ko DC; Kim SY; Valdivia RH; Bastidas RJ; Coers J
Cell Host Microbe; 2022 Dec; 30(12):1671-1684.e9. PubMed ID: 36084633
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic rescue of Chlamydia trachomatis growth in IFN-gamma treated mouse cells by irradiated Chlamydia muridarum.
Nelson DE; Taylor LD; Shannon JG; Whitmire WM; Crane DD; McClarty G; Su H; Kari L; Caldwell HD
Cell Microbiol; 2007 Sep; 9(9):2289-98. PubMed ID: 17501981
[TBL] [Abstract][Full Text] [Related]
17. Cell-autonomous
Pradipta A; Sasai M; Motani K; Ma JS; Lee Y; Kosako H; Yamamoto M
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34078740
[TBL] [Abstract][Full Text] [Related]
18. Identification of the microsporidian Encephalitozoon cuniculi as a new target of the IFNγ-inducible IRG resistance system.
Ferreira-da-Silva Mda F; Springer-Frauenhoff HM; Bohne W; Howard JC
PLoS Pathog; 2014 Oct; 10(10):e1004449. PubMed ID: 25356593
[TBL] [Abstract][Full Text] [Related]
19. IFNγ and Antibody Synergize To Enhance Protective Immunity against Chlamydia Dissemination and Female Reproductive Tract Reinfections.
Gann JI; Malaviarachchi PA; Du W; Mercado MAB; Li LX
Infect Immun; 2022 Dec; 90(12):e0032822. PubMed ID: 36374101
[TBL] [Abstract][Full Text] [Related]
20. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice.
Bernstein-Hanley I; Coers J; Balsara ZR; Taylor GA; Starnbach MN; Dietrich WF
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14092-7. PubMed ID: 16959883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
